For the Inventor, By the Inventor

Enter assignee name

New Delhi, Delhi, India

Ranbaxy Laboratories, Inc.

USPTO Granted Patents = 157

EPO Patents = 28

Trademarks = 6

Forward Citations = 455

Loading Chart...

Loading Chart...

253 inventors (with patents filed for the assignee):

Yatendra Kumar (36 out of 37 patents)

Mohan Prasad (30 out of 43 patents)

Anita Mehta (21 out of 23 patents)

4. Rajesh Kumar Thaper (16 out of 17 patents)

5. Jag Mohan Khanna (15 out of 15 patents)

6. Jang Bahadur Gupta (14 out of 15 patents)

7. Naresh Kumar (13 out of 27 patents)

8. Swargam Sathyanarayana (11 out of 12 patents)

9. Mahavir Singh Khanna (9 out of 13 patents)

10. Abhijit Ray (9 out of 9 patents)

11. Mohammad Salman (9 out of 12 patents)

12. Himadri Sen (9 out of 9 patents)

13. Sudershan Kumar Arora (8 out of 17 patents)

14. Venkata Poornapragnacharyulu Palle (8 out of 104 patents)

15. Sanjay Kumar Jain (7 out of 26 patents)

Core Competencies:

Dabigatran Etexilate

Asenapine Maleate

Doxycycline

Tigecycline

Dexlansoprazole

Meropenem

Sunitinib

Febuxostat

Lacosamide

Matrix Metalloproteinase Inhibitors

Aprepitant

Atorvastatin Calcium

157 patents: Sort by Forward Citations

1. 9150542 - Process for the preparation of crystalline form I of methanesulfonate salt of dabigatran etexilate (2015-10-06),

2. 9145421 - Process for the preparation of asenapine maleate (2015-09-29),

3. 9132092 - Pharmaceutical composition of doxycycline (2015-09-15),

4. 9107929 - Stable parenteral formulations of tigecycline (2015-08-18),

5. 9085592 - Process for the preparation of fosamprenavir calcium (2015-07-21),

6. 9085556 - Salts of dexlansoprazole and their preparation (2015-07-21),

7. 9078830 - Multi-layered, multiple unit pharmaceutical compositions (2015-07-14),

8. 9000150 - Process for the preparation of pure meropenem trihydrate (2015-04-07),

9. 8916716 - Process for the preparation of crystalline form II of L-malic acid salt of sunitinib (2014-12-23),

10. 8916713 - Process for the preparation of febuxostat (2014-12-23),

11. 8911787 - Stable oral benzimidazole compositions and process of preparation thereof (2014-12-16),

12. 8871932 - Process for the preparation of tadalafil (2014-10-28),

13. 8853453 - Processes for reducing impurities in lacosamide (2014-10-07),

14. 8853411 - Process for the preparation of dexlansoprazole (2014-10-07),

15. 8846910 - Matrix metalloproteinase inhibitors (2014-09-30),

Ranbaxy Laboratories, Inc. is a renowned global pharmaceutical company. It operates in various countries and specializes in the development, production, and marketing of generic and branded medicines. Ranbaxy is committed to improving the health and well-being of people around the world by providing high-quality, affordable healthcare solutions. With a strong focus on research and development, Ranbaxy continues to introduce innovative products to address the ever-evolving healthcare needs of patients.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 23 2025

157 Patents

#1 in New Delhi, Delhi

#11 in India

#5,096 in the World

New Delhi, Delhi, India

Ranbaxy Laboratories, Inc.

Forward Citations = 455

253 inventors:

Yatendra Kumar (36 out of 37 patents)

Mohan Prasad (30 out of 43 patents)

Anita Mehta (21 out of 23 patents)

4. Rajesh Kumar Thaper (16 out of 17 patents)

5. Jag Mohan Khanna (15 out of 15 patents)

Please report any incorrect information to support@idiyas.com

Loading…